Updates on the C27 research, the consortium and the people behind it.
C27-IMAGE passes the first FORESIGHT check
The C27-IMAGE research proposal, submitted to the FORESIGHT programme of Health~Holland on 1 November, has passed the first check. FORESIGHT has confirmed that the application is eligible and moves on to the scientific evaluation.
An evaluation committee will now assess the content of the proposal. Around the end of November it will be decided whether the consortium is invited to submit a full proposal. This is a first step; the scientific evaluation is still to come.
Prof. Jian-Ping Jin visits the Netherlands Heart Institute
From left: Prof. Francesca Stillitano, Femke Pol, Mark Hage, Prof. Jolanda van der Velden and Prof. Jian-Ping Jin.
On 29 and 30 October, Prof. Jian-Ping Jin of the University of Illinois Chicago, the inventor of the C27 technology, visited the Netherlands Heart Institute (NLHI) in Utrecht. He gave a keynote lecture on his research into cardiac troponin I at a meeting of PRECISE, the national consortium for inherited heart disease.
Prof. Jin also met the C27 research team in person, and the visit was an opportunity to discuss the next steps of the C27-IMAGE research proposal together. He indicated that he would like to stay closely involved with the consortium in the long term.
Bringing the inventor of C27 together with the Dutch teams that work with the patient-specific heart models is an important step for the project. It connects the original laboratory research directly to the next phase: testing C27 in heart tissue grown from cells of the children themselves.
“There is of course still a great deal to do, but these were two very special days for me.” — Mark Hage
